-
Ocular Therapeutix Inc., Bedford, Mass. Business: Ophthalmic Date announced: 6/10/13 Ocular Therapeutix raised an undisclosed amount in an extension of its series D round. Baxter Ventures and Ascension Health Ventures …
Published on 6/17/2013
-
Ohr Pharmaceutical Inc. (NASDAQ:OHRP), Salt Lake City, Utah Business: Ophthalmic, Endocrine/Metabolic, Cancer Date announced: 6/12/13 Ohr began trading on NASDAQ under the symbol "OHRP." Previously, the stock traded on …
Published on 6/17/2013
-
PDL BioPharma Inc. (NASDAQ: PDLI), Incline Village, Nev. Business: Antibodies Date announced: 6/12/13 PDL BioPharma paid a regular quarterly dividend of $0.15 per share on June 12 to stockholders of record as of June 5.…
Published on 6/17/2013
-
Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX), Montreal, Quebec Business: Neurology, Dermatology Date announced: 6/7/13 Valeant filed a shelf registration covering the sale of up to $3 billion of its …
Published on 6/17/2013
-
ValiRx plc (LSE:VAL), London, U.K. Business: Cancer, Diagnostic Date announced: 6/6/13 ValiRx said it was admitted to the Social Stock Exchange (SSE) as a founding member. According to its website, the London-based SSE…
Published on 6/17/2013
-
Agios Pharmaceuticals Inc., Cambridge, Mass. Business: Cancer Date announced: 6/10/13 Type: IPO To be raised: Up to $86 million Shares: TBD Price: TBD Underwriters: JPMorgan; Goldman Sachs; Cowen; Leerink
Published on 6/17/2013
-
Conatus Pharmaceuticals Inc., San Diego, Calif. Business: Inflammation, Infectious, Endocrine/Metabolic Date announced: 6/14/13 Type: IPO To be raised: Up to $69 million Shares: TBD Price: TBD Underwriters: Stifel, …
Published on 6/17/2013
-
Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), New York, N.Y. Business: Hepatic, Endocrine/Metabolic Date announced: 6/10/13 Type: Follow-on To be raised: Up to $63.3 million Shares: 1.7 million Price prior: $33.65 …
Published on 6/17/2013
-
Valneva SE (Euronext:VLA; VSE:VLA), Lyon, France Business: Antibodies, Infectious Date announced: 6/13/13 Type: Rights offering To be raised: Up to 40.2 million ($53 million) Shares: 15.2 million Price: 2.65 …
Published on 6/17/2013
-
bluebird bio Inc., Cambridge, Mass. Business: Gene/Cell therapy, Hematology, Neurology Date announced: 6/4/13 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: JPMorgan; BofA …
Published on 6/10/2013
-
PTC Therapeutics Inc., South Plainfield, N.J. Business: Pulmonary, Cancer, Infectious Date announced: 6/5/13 Type: IPO To be raised: Up to $110.4 million Shares: 6.9 million Price: $13-$16 Underwriters: JPMorgan; Credit…
Published on 6/10/2013
-
Akebia Therapeutics Inc., Cincinnati, Ohio Business: Hematology, Cardiovascular Date completed: 6/4/13 Type: Venture financing Raised: $41 million Investors: Satter Investment Management; Novo A/S; Novartis Venture …
Published on 6/10/2013
-
Arcturus Therapeutics Inc., San Diego, Calif. Business: Hepatic, Neurology Date completed: 6/3/13 Type: Venture financing Raised: $1.3 million Investors: Private investors
Published on 6/10/2013
-
Array BioPharma Inc. (NASDAQ:ARRY), Boulder, Colo. Business: Cancer, Inflammation, Chemistry Date completed: 6/4/13 Type: Private placement of senior convertible notes Raised: $132.3 million Underwriters: Goldman Sachs;…
Published on 6/10/2013
-
BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date completed: 6/6/13 Type: Direct public offering Raised: $9.1 million Units: 2.2 million Price: $4.16 (unit) Shares after …
Published on 6/10/2013
-
Celsion Corp. (NASDAQ:CLSN), Lawrenceville, N.J. Business: Drug delivery, Cancer Date completed: 5/31/13 Type: Direct public offering Raised: $9.8 million Shares: 6.3 million Price: $1.57 Shares after offering: 57.9 …
Published on 6/10/2013
-
Critical Outcome Technologies Inc. (TSX-V:COT), London, Ontario Business: Cancer, Autoimmune, Infectious Date completed: 6/3/13 Type: Private placement of units Raised: C$289,488 ($279,133) Units: 2.4 million Price: C$0…
Published on 6/10/2013
-
Edge Therapeutics Inc., Newark, N.J. Business: Neurology, Drug delivery Date completed: 6/4/13 Type: Venture financing Raised: $18 million Investors: Private investors Placement agent: Maxim Group
Published on 6/10/2013
-
Inflection Biosciences Ltd., Blackrock, Ireland Business: Cancer Date completed: 6/3/13 Type: Venture financing Raised: 450,000 ($585,000) Investors: Private investor; Enterprise Ireland
Published on 6/10/2013
-
InVivo Therapeutics Holdings Corp. (OTCBB:NVIV), Cambridge, Mass. Business: Neurology Date completed: 6/4/13 Type: Warrant exercise Raised: $16.1 million Shares: 11.5 million Price: Not disclosed Shares after offering: …
Published on 6/10/2013
-
Lumicell Diagnostics Inc., Waltham, Mass. Business: Diagnostic Date completed: 5/29/13 Type: Venture financing Raised: $1 million Investor: Massachusetts Life Sciences Center Note: The offering is a loan.
Published on 6/10/2013
-
Mercator MedSystems Inc., San Leandro, Calif. Business: Drug delivery Date completed: 5/30/13 Type: Venture financing Raised: $6.5 million Investors: Volcano Capital; Crocker Capital; Aphelion Capital; Windy City; SET …
Published on 6/10/2013
-
Nordic Nanovector A/S, Oslo, Norway Business: Cancer Date completed: 6/5/13 Type: Venture financing Raised: NOK60.8 million ($10.4 million) Investors: New investors; individual investors
Published on 6/10/2013
-
Orion Corp. (HSE:ORNAV; HSE:ORNBV), Espoo, Finland Business: Neurology, Cardiovascular, Endocrine/Metabolic Date completed: 6/4/13 Type: Bond Raised: 150 million ($195 million) Underwriter: Pohjola Markets Note: The 2.…
Published on 6/10/2013
-
PeptiDream Inc., Tokyo, Japan Business: Supply/Service Date completed: 5/31/13 Type: IPO Raised: 5.2 billion ($52.4 million) Shares: 2.1 million Price: 2,500 Shares after offering: 13.2 million Underwriters: Mizuho; and…
Published on 6/10/2013